Aboleris Pharma
5 known investors
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
Founders & leadership
IA
Ignacio AnegonCo-founder, Senior Consultant & SAB Member
CG
Carole GuillonneauCo-founder & Head of Research
FH
François-Xavier HubertCo-founder, Past President & Board Member